Document Detail


The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
MedLine Citation:
PMID:  23208789     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Pharmacovigilance methods have advanced greatly during the last decades, making post-market drug assessment an essential drug evaluation component. These methods mainly rely on the use of spontaneous reporting systems and health information databases to collect expertise from huge amounts of real-world reports. The EU-ADR Web Platform was built to further facilitate accessing, monitoring and exploring these data, enabling an in-depth analysis of adverse drug reactions risks. METHODS: The EU-ADR Web Platform exploits the wealth of data collected within a large-scale European initiative, the EU-ADR project. Millions of electronic health records, provided by national health agencies, are mined for specific drug events, which are correlated with literature, protein and pathway data, resulting in a rich drug-event dataset. Next, advanced distributed computing methods are tailored to coordinate the execution of data-mining and statistical analysis tasks. This permits obtaining a ranked drug-event list, removing spurious entries and highlighting relationships with high risk potential. RESULTS: The EU-ADR Web Platform is an open workspace for the integrated analysis of pharmacovigilance datasets. Using this software, researchers can access a variety of tools provided by distinct partners in a single centralized environment. Besides performing standalone drug-event assessments, they can also control the pipeline for an improved batch analysis of custom datasets. Drug-event pairs can be substantiated and statistically analysed within the platform's innovative working environment. CONCLUSIONS: A pioneering workspace that helps in explaining the biological path of adverse drug reactions was developed within the EU-ADR project consortium. This tool, targeted at the pharmacovigilance community, is available online at https://bioinformatics.ua.pt/euadr/. Copyright © 2012 John Wiley & Sons, Ltd.
Authors:
José Luis Oliveira; Pedro Lopes; Tiago Nunes; David Campos; Scott Boyer; Ernst Ahlberg; Erik M van Mulligen; Jan A Kors; Bharat Singh; Laura I Furlong; Ferran Sanz; Anna Bauer-Mehren; Maria C Carrascosa; Jordi Mestres; Paul Avillach; Gayo Diallo; Carlos Díaz Acedo; Johan van der Lei
Related Documents :
21934629 - Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in ...
24930409 - Prescribing pattern and indicators for performance in a psychiatric practice.
25204519 - The potential role of nano- and micro-technology in the management of critical illnesses.
19842299 - Multiple drug use and polydrug use amongst homeless traveling youth.
3779179 - A drug policy for our times.
6917769 - Intercollegiate sports participation and non-medical drug use.
12397839 - Psychoactive drug interactions with pharmacotherapy for diabetes.
9151499 - Arthropod succession on exposed carrion in three contrasting tropical habitats on hawai...
23016639 - Targeted blood-to-brain drug delivery 10 key development criteria.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-4
Journal Detail:
Title:  Pharmacoepidemiology and drug safety     Volume:  -     ISSN:  1099-1557     ISO Abbreviation:  Pharmacoepidemiol Drug Saf     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9208369     Medline TA:  Pharmacoepidemiol Drug Saf     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Affiliation:
DETI/IEETA, University of Aveiro, Aveiro, Portugal. jlo@ua.pt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluating dynamic treatment strategies: does it have to be more costly?
Next Document:  MR Lymphangiography for Assessment of Focal Dermal Backflow for Presurgical Work-Up in Patients with...